Table 1 Perioperative data to be collected
Period | Data |
|---|---|
Preoperative data | Surgery date Study center Age Sex Weight Height Body mass index Race ASA Physical Status Smoking status Functional status (The Eastern Cooperative Oncology Group [ECOG] performance status) Unrestricted clear fluid ingestion until 2Â h before anesthesia Unrestricted CHO-contained fluid ingestion until 2Â h before anesthesia Charlson Comorbidity Index Neoadjuvant therapy Clinical stage (The American Joint Committee on Cancer [AJCC] 8th |
Operative data | Operative approach Operation name Duration of surgery Duration of anesthesia Intraoperative fluid volume Intraoperative transfusion Intraoperative use of steroids Intraoperative use of opioid Intraoperative adjuvants (ketamine, dexmedetomidine, lidocaine, Steroids, NSAIDs) Use and type of analgesia |
Postoperative data | Pathological stage (AJCC 8th) Cell type Tumor size Resection margin Vascular invasion Lymphatic invasion Perineural invasion Visceral pleural involvement Tumor necrosis Mutation Postoperative adjuvant treatment Date of hospital discharge Date of local recurrence Date of metastasis Date of death Cause of death Postoperative complications (Clavien-Dindo classification, STS general thoracic surgery databases) Additional surgeries during the follow-up period and their reason Date of last follow-up |